GB1507198A - Antihemophilic factor - Google Patents

Antihemophilic factor

Info

Publication number
GB1507198A
GB1507198A GB14817/75A GB1481775A GB1507198A GB 1507198 A GB1507198 A GB 1507198A GB 14817/75 A GB14817/75 A GB 14817/75A GB 1481775 A GB1481775 A GB 1481775A GB 1507198 A GB1507198 A GB 1507198A
Authority
GB
United Kingdom
Prior art keywords
extract
temperature
cryoprecipitate
precipitate
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14817/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of GB1507198A publication Critical patent/GB1507198A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB14817/75A 1974-04-12 1975-04-10 Antihemophilic factor Expired GB1507198A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46041774A 1974-04-12 1974-04-12

Publications (1)

Publication Number Publication Date
GB1507198A true GB1507198A (en) 1978-04-12

Family

ID=23828619

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14817/75A Expired GB1507198A (en) 1974-04-12 1975-04-10 Antihemophilic factor

Country Status (5)

Country Link
JP (1) JPS50142719A (OSRAM)
CA (1) CA1045032A (OSRAM)
DE (1) DE2516186A1 (OSRAM)
FR (1) FR2267113B1 (OSRAM)
GB (1) GB1507198A (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739039A (en) * 1985-11-08 1988-04-19 Baxter Travenol Laboratories, Inc. Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4302445A (en) * 1980-01-18 1981-11-24 Institut Merieux Method for concentrating and purifying antihemophilic factor or factor VIII
JPS5867627A (ja) * 1981-10-12 1983-04-22 ア−マ−・フア−マシユ−テイカル・カンパニ− 高純度抗血友病性因子の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739039A (en) * 1985-11-08 1988-04-19 Baxter Travenol Laboratories, Inc. Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product

Also Published As

Publication number Publication date
FR2267113B1 (OSRAM) 1979-08-24
CA1045032A (en) 1978-12-26
JPS50142719A (OSRAM) 1975-11-17
DE2516186A1 (de) 1975-10-30
FR2267113A1 (OSRAM) 1975-11-07

Similar Documents

Publication Publication Date Title
US3973002A (en) Antihemophilic factor
CA2113660C (en) Process for the obtention of biological adhesive made of concentrated coagulation factors by salting-out
Jaffe et al. Synthesis of basement membrane collagen by cultured human endothelial cells.
Mowbray Effect of large doses of an α2-glycoprotein fraction on the survival of rat skin homografts
US4251510A (en) Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
DK1007061T3 (da) Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater
JPS596845B2 (ja) 抗血友病因子の収率改良法
AU8476698A (en) Human mesenchymal stem cells from peripheral blood
CA2021581A1 (en) Improved stable coagulation controls
JPS57118520A (en) Method of selectively increasing yield and purity of low temperature precipitation protein
CA2330389A1 (en) Method for preparing a diafiltered stabilized blood product
AU549584B2 (en) Heat stabilization of plasma proteins
GB8914968D0 (en) Production of virus and purification of viral envelope proteins for vaccine use
US3227626A (en) Plasminogen heat sterilization
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
ES2051909T3 (es) Vacuna del conjugado de polisacarido-proteina de membrana externa contra la haemophilus influenzae tipo b.
US3434929A (en) Process for purifying plasmin
CA1213827A (en) Process for pasteurizing fibronectin
AUPQ347199A0 (en) Novel polypeptide fragments
US5830739A (en) Proteolytic mixture containing escharase and method of isolating same
JPS61189228A (ja) 血液凝固第８因子製剤の製法
Husain et al. Purification of a new high MW single chain form of urokinase (UK) from urine
CA1045032A (en) Antihemophilic factor
US3713981A (en) Enzymes from armillaria mellea
FI91710B (fi) Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee